Mukka Proteins Q4 FY26: Growth in scale, margins under pressure, and a bigger ESG platform

Mukka Proteins Limited closed FY26 with a clearer story than a typical fishmeal exporter. It is trying to be an integrated animal protein and sustainability platform, with fish protein still at the center, but supported by insect biotechnology, municipal waste solutions, and a growing frozen seafood arm. The numbers show both progress and the costs of scaling.

For FY26, revenue from operations rose to ₹1,449.5 crore from ₹1,006.4 crore in FY25. EBITDA increased to ₹145.3 crore from ₹111.2 crore, but the EBITDA margin softened to 10.0 percent from 11.0 percent. Profit after tax rose to ₹57.1 crore from ₹48.1 crore, while PAT margin declined to 3.9 percent from 4.8 percent. Finance costs moved up sharply to ₹53.6 crore in FY26 from ₹37.3 crore in FY25, which helps explain why profit growth did not keep pace with revenue growth.

Quarterly performance was more volatile. Q4 FY26 revenue from operations was ₹380.6 crore versus ₹381.6 crore in Q4 FY25, and materially lower than Q3 FY26 at ₹653.5 crore. Profit after tax in Q4 FY26 was ₹21.4 crore compared with ₹14.0 crore in Q4 FY25, though lower than ₹27.3 crore in Q3 FY26. The presentation also shows Q4 FY26 EBITDA margin at 12.9 percent, indicating stronger profitability in the quarter even as revenue moderated.

The core point for investors is that Mukka’s financial year reflects expansion and integration across multiple verticals, while the quarter reflects normalisation from a strong Q3 and a business that remains exposed to commodity cycles, working capital intensity, and the cost of growth.

FY26 in numbers: higher revenue, softer margins

The annual financials underline two realities. First, the company has scaled meaningfully. FY26 total income was ₹1,478.2 crore, up from ₹1,021.5 crore in FY25. Second, the cost base and funding costs rose with that scale. Cost of materials consumed increased to ₹1,430.7 crore from ₹916.1 crore. Finance costs increased to ₹53.6 crore from ₹37.3 crore.

Inventory changes also played a large role in reported profitability, with changes in inventories of finished goods and work in progress at negative ₹261.4 crore in FY26 versus negative ₹141.4 crore in FY25. This line item can swing year to year in businesses linked to export cycles and raw material availability.

The result was growth in absolute EBITDA and PAT, but lower profitability ratios. EBITDA margin moved down by 100 basis points to 10.0 percent. PAT margin declined by 90 basis points to 3.9 percent.

The quarter adds context. Q4 FY26 delivered PAT of ₹21.4 crore on revenue of ₹380.6 crore. Q3 FY26 had much higher revenue at ₹653.5 crore and PAT of ₹27.3 crore. That spread signals timing effects that are common in export-heavy businesses.

Four verticals, one platform: why diversification matters

Mukka’s investor presentation describes a shift from fishmeal to an integrated platform across fish protein, insect protein, waste management, and frozen seafood. The strategy is meant to reduce cyclicality, widen the addressable market, and create ESG-aligned revenue streams.

The fish protein business remains the anchor. The company positions itself as a leading export-focused marine protein platform with about 25 to 30 percent share of Indian fish protein exports. It highlights consistent high protein content in fishmeal, at 60 to 65 percent, custom formulations, and long-term export relationships. End markets are weighted to aquaculture at over 90 percent, with smaller participation in poultry, pet food, veterinary pharma, and industrial applications.

Fish oil adds a second leg within marine ingredients. The presentation notes omega-3 rich marine lipids, with end uses split across aquaculture at 63 percent, omega-3 supplements at 16 percent, and other uses at 21 percent including biofuel, swine feed, pet food, and cooking oil. It also highlights centrifuged fish oil produced from sardines and mackerels for industrial applications like coatings, chemicals, lubricants, and greases.

Fish soluble paste completes the circular manufacturing loop. It is presented as a by-product of the fishmeal process, where protein water is evaporated into a semi-viscous liquid with 40 to 50 percent moisture and about 40 percent protein content. It is used to improve feed palatability and nutrition, especially for shrimp and fish diets.

Beyond marine ingredients, Mukka is building an alternate proteins vertical based on Black Soldier Fly biotechnology. The company positions itself as a pioneer in India’s BSF-based insect protein and compost industry, converting municipal wet waste into insect meal, insect oil, insect compost, humic acid, and briquettes. Capacity is disclosed across sites: 200 TPD in Mangaluru, 1,000 TPD in Bengaluru, and 200 TPD in Kochi. The logic is both operational and commercial. The process addresses urban wet waste challenges, enables a circular economy impact with zero leachate and zero landfill claims, and creates a fishmeal substitute that can serve Mukka’s aquafeed customer base.

Waste management is the third vertical and is framed as a high-barrier, recurring environmental infrastructure platform. The company describes leachate management for government bodies with fees from municipalities and the possibility of carbon credit upside. A key project is the Bengaluru leachate treatment order, with order value of ₹474.89 crore ex-GST, capex of about ₹100 crore, a 6-month build timeline and a 4-year project duration. Mukka’s JV stake is stated at 76 percent.

The fourth vertical is frozen and value-added seafood. It is described as an EU-approved, export-focused platform enabling forward integration and margin diversification. Products include surimi and IQF and blast frozen seafood across multiple species. The company also discloses combined capacity. Across Ocean Proteins and Mukka Frozen Impex along with MPL, total combined freezing capacity is 167 TPD and cold storage is 1,926 TPD.

This diversification is not only about adding new revenue streams. It is also about controlling raw material and improving monetisation. Fish protein scale supports export relationships. Frozen seafood improves value capture from marine sourcing. Insects and waste solutions link to ESG and regulatory tailwinds.

Execution signals: Oman, Sri Lanka, and MarinTrust alignment

In FY26, Mukka highlighted operational milestones that point to wider geographic and regulatory reach.

First, the company is expanding in Oman. It has an upcoming facility in the Aljoubah Industrial Area spread over 21,249 square meters, with operations expected to commence in the coming quarters. Oman is presented as a supply chain advantage because it offers direct access to high-quality raw material and proximity to GCC and export markets.

Second, it is expanding into Sri Lanka for manufacturing and trading of marine products and allied operations. While the presentation does not disclose timelines or capacities for Sri Lanka, the inclusion signals intent to deepen regional sourcing and trading reach.

Third, the company is positioning itself for global compliance through acceptance under the MarinTrust Improver Programme. Confirmation was received from Global Trust Certification, NSF, Ireland. The company highlights benefits like improved supply chain transparency and responsible sourcing, better alignment with standards such as BAP, ASC, and Global G.A.P., and reduced sourcing risks through traceable, FIP-linked supply chains.

This matters because marine ingredient markets are increasingly shaped by traceability and certification expectations from global aquaculture and feed customers. For a business with 79.7 percent export revenue share in FY26, compliance readiness can influence customer retention and pricing.

The presentation also stresses global scale. Mukka has a presence across 25 plus countries. It notes 24 manufacturing units including third party and job units, and 16 owned in-house production facilities in India and Oman. This footprint supports the company’s stated view of itself as a platform rather than a commodity producer.

The investor lens: opportunities, constraints, and what to watch

Mukka’s market context section leans on structural drivers that support demand for marine ingredients and alternative proteins.

For fish protein, the presentation describes a structurally supply-constrained market with limited new capacity additions. It cites a global annual fishmeal and fish oil market of about 5 to 6 million metric tonnes, and demand growth of about 5 percent CAGR over 2024 to 2030 driven by aquaculture expansion. It also highlights a future supply tension, referencing Rabobank on fishmeal shortage expected from 2028 and pointing to climate impacts and El Niño disruptions.

For alternate proteins, the company cites a global insect protein market size of about $1 billion and expected growth of about 25 percent CAGR over the medium term. The message is that novel feed sources become essential rather than optional, aligning with IFFO’s direction and the wider push for resilient, sustainable aquaculture feed.

For waste management, the opportunity is framed through high entry barriers and annuity-like government contracts in under-penetrated leachate treatment and waste-to-value. The company also frames this as part of its ESG platform. It reports 100,000 plus tonnes of wet waste diverted from landfills and states zero landfill and zero leachate outcomes, alongside lower greenhouse gas emissions. It also notes carbon credit approvals for 1,200 TPD, split as EPPL 200 TPD, MPL 300 TPD advanced toward carbon credit issuance, and incremental 700 TPD approved.

Investors should still reconcile the opportunity with near-term financial signals. FY26 growth came with margin pressure and higher finance costs. The company’s growth outlook targets revenue above ₹3,000 crore by FY30 from ₹1,449 crore in FY26, implying more than 2x growth in about four years. Achieving this will likely require steady execution across multiple geographies, disciplined capex, and control over working capital and funding costs.

Q4 shows that profitability can improve even when revenue is lower, but the broader year indicates that scaling the platform is not margin-neutral. A key question is how quickly the new verticals and projects can add stable cash flows that reduce cyclicality.

Takeaways: scaling an integrated protein and sustainability platform

Mukka Proteins ended FY26 with stronger scale and a broader operating platform. Revenue grew sharply year on year, and absolute EBITDA and PAT improved. But margins softened and finance costs increased, showing the cost of growth and the working capital intensity of an export-led model.

Strategically, the company is building around four linked verticals: fish protein as the anchor, frozen seafood for forward integration, insect biotech for alternative feed and waste-to-value outputs, and leachate management for high-barrier municipal contracts. The Oman expansion, the move into Sri Lanka, and alignment with the MarinTrust Improver Programme strengthen the case that the company is preparing for a more compliance-driven and geographically diversified growth path.

The FY26 theme is disciplined expansion with an ESG spine. The near-term investor focus should remain on margin stability, funding costs, and execution on the Bengaluru leachate project and the upcoming Oman facility. If those pieces land as planned, Mukka’s platform approach could make its earnings less cyclical than a pure fishmeal exporter over the next few years.